文献速递消化、代谢与肾脏急症儿科与产科急症

外用辣椒素与外用吡罗昔康治疗急性创伤性疼痛的比较:一项随机双盲试验

Comparison of topical capsaicin and topical piroxicam in the treatment of acute trauma-induced pain: A randomized double-blind trial.
PubMed 文献 · Am J Emerg Med · 2020-06-02
一句话结论急诊急性肌肉骨骼损伤患者中,外用辣椒素在60分钟至72小时的疼痛缓解和临床疗效上均优于外用吡罗昔康,且副作用无显著差异。

该前瞻性随机双盲对照研究比较了外用辣椒素与外用吡罗昔康在急性肌肉骨骼损伤中的镇痛效果,纳入吡罗昔康组67例和辣椒素组69例。辣椒素组在各测量时间点的VAS评分下降均值及下降百分比均显著更高,72小时VAS变化差异最大(均值差分别为1.53,95%CI 0.85-2.221;19.7,95%CI 12.4-27.2,p<0.001)。辣椒素组临床疗效显著更高(p<0.01),两组副作用无显著差异。作者认为,外用辣椒素初始及随访中可作为外用吡罗昔康的替代选择。

要点

  • 在急诊急性肌肉骨骼损伤患者中,外用辣椒素组各时间点VAS评分下降均值均显著高于外用吡罗昔康组(p<0.001)。
  • 72小时VAS变化差异最大:VAS评分下降均值差1.53(95%CI 0.85-2.221),下降百分比均值差19.7(95%CI 12.4-27.2)。
  • 辣椒素组临床疗效显著更高(p<0.01),两组间治疗结局的临床有效性差异亦具统计学意义(p<0.001)。
  • 两组副作用出现情况无显著差异。
  • 作者认为,外用辣椒素初始及随访中可作为外用吡罗昔康的替代选择用于急诊急性疼痛患者。

适用人群与场景

  • 急诊就诊的急性肌肉骨骼损伤患者,吡罗昔康组67例,辣椒素组69例。

处置流程与药物剂量

  • 外用辣椒素与外用吡罗昔康作为局部镇痛药物进行比较,具体剂量、浓度、给药频次及疗程原文未写明。

研究设计与关键结果

  • 前瞻性、随机、对照、双盲研究,比较外用辣椒素与外用吡罗昔康在急性肌肉骨骼损伤中的镇痛效果,吡罗昔康组67例,辣椒素组69例。
  • 辣椒素组各测量时间点VAS评分下降均值均显著高于吡罗昔康组。
  • 辣椒素组VAS评分下降百分比均值显著高于吡罗昔康组。
  • 72小时VAS变化差异最大:下降均值差1.53(95%CI 0.85-2.221),下降百分比均值差19.7(95%CI 12.4-27.2),p<0.001。
  • 辣椒素组临床疗效显著更高(p<0.01),两组治疗结局的临床有效性差异具统计学意义(p<0.001)。
  • 两组副作用出现情况无显著差异。

证据类型、等级与局限

  • 证据类型:前瞻性随机双盲对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对急诊就诊的急性疼痛患者,外用辣椒素初始及随访中可作为外用吡罗昔康的替代选择,因两组副作用无显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: This study aimed to compare the analgesic efficacy of topical capsaicin and topical piroxicam in acute musculoskeletal injuries.

METHODS: This is a prospective, randomized, controlled, double-blinded study. The data for the 67 patients in the piroxicam group and the 69 in the capsaicin group were examined. The initial visual analog scale (VAS) scores were compared with the 60th and 120th minute as well as the 24th and 72nd hour values. Differences between the VAS scores, clinical effectiveness of the treatment and side effects were evaluated.

RESULTS: In the capsaicin group, the mean difference in the delta VAS scores was significantly higher at each measurement time. The mean of the percentage of reduction in the VAS scores of the topical capsaicin group was significantly higher than that in the topical piroxicam group. The highest difference in terms of both outcomes was determined at the 72nd hour VAS change. Mean differences were 1.53 (95% CI: 0.85-2.221) and 19.7 (95% CI: 12.4-27.2) respectively (p < 0.001). In the capsaicin group, the clinical effect of the treatment was found significantly higher (p < 0.01). The difference between the clinical effectiveness of the groups regarding the treatment outcomes was also statistically significant (p < 0.001). There was no significant difference between the patient groups regarding the presence of side effects.

CONCLUSION: Topical capsaicin can be used as an alternative to topical piroxicam initially and at follow-up in patients presenting to the emergency department with acute pain as there were no observable differences in side-effects between the two groups.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Kocak AO, Dogruyol S, Akbas I, et al. Comparison of topical capsaicin and topical piroxicam in the treatment of acute trauma-induced pain: A randomized double-blind trial. Am J Emerg Med. 2020. PMID: 32739846. doi:10.1016/j.ajem.2020.05.104

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。